Barbara Ryan | IR |
Greg Williams | CEO |
Neil Belloff | COO and General Counsel |
Matthew Goddeeris | VP, Research |
Tom Haverty | Chief Medical Officer |
Stephen MacDonald | VP-Finance and Accounting |
Good afternoon everyone and welcome to Eloxx Pharmaceuticals Third Quarter 2020 earnings webcast and conference call. [Operator Instructions] At this time, I would like to turn the call over to Barbara Ryan, Eloxx Investor Relations. Please begin.
Thank you, operator. Welcome and thank you for joining us this afternoon for a review of Eloxx Pharmaceuticals Third Quarter 2020 financial results and business update.